Brain implant allows ALS patient to control Amazon’s Alexa with thought: ‘Gives me back the independence that I’m losing’
To be able to manage important aspects of my environment and control access to entertainment gives me back the independence that I’m losing.”
ALS Patient Uses Synchron Brain-Chip Interface to Control Smart Devices Through Thought
Synchron has announced one of its patients with ALS is now able to control devices using only his mind with the company's brain chip implant.
Brain implant lets man with amyotrophic lateral sclerosis control Amazon's Alexa with his thoughts
A patient with a degenerative disease was able to command Amazon's Alexa digital assistant with his mind, the company behind the
Synchron Connects Brain Implant to Amazon Alexa
Synchron is one of several companies working to make brain-computer interfaces (BCIs) a reality. Earlier this summer, Synchron revealed one of its study participants could use the Apple Vision Pro VR headset thanks to the Synchron implant.
64-year-old ALS patient controls Alexa with just his thoughts
A 64-year-old ALS patient successfully controlled Alexa using his thoughts through a brain implant, allowing him to perform tasks like making video calls, playing music, and operating smart home devices.
Man controls Amazon Alexa with his thoughts, ‘It gives me back the independence’
An ALS patient manipulated Amazon's Alexa through a brain implant, enabling him to control devices and stream shows mentally. This advancement illustrates the potential of brain-computer interfaces to provide independence to those with degenerative diseases,
ALS patient uses brain chip to control Alexa, shop, stream with just thoughts
On Monday, Synchron, a brain-computer interface (BCI) company, announced this development, revealing that the 64-year-old patient, diagnosed with amyotrophic lateral sclerosis (ALS), can stream shows,
New research identifies potential therapeutic target for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...
WebMD12d
Amyotrophic Lateral Sclerosis (ALS)
Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.
Pharmaceutical Technology12d
Fasudil by Woolsey Pharmaceuticals for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis.
Medical Xpress24d
New insights into the pathogenesis of amyotrophic lateral sclerosis
The symptoms of amyotrophic lateral sclerosis (ALS)—a neurodegenerative disease that involves loss of nerve cells that control movement—tend to emerge in adulthood. To Davide Trotti ...
Nature1mon
Amyotrophic lateral sclerosis articles from across Nature Portfolio
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty ...
Pharmaceutical Technology12d
Siplizumab by ITB-Med for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Siplizumab is under clinical development by ITB-Med and currently in Phase I for Amyotrophic Lateral Sclerosis.
Daily10d
Zydus Lifesciences completes Phase II(a) clinical trial of Usnoflast in patients with Amyotrophic Lateral Sclerosis
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, announced the completion of its Phase II(a) clinical ...
FierceBiotech1d
After Alzheimer's stumble, Athira lays off 70% of workforce and pivots to ALS small molecule
Athira Pharma has been on a bumpy road in recent years, and now the company is restructuring and shedding weight to try to ...